A CCTA Image Assisted Triage Software for the Assessment of Patients With Suspected Coronary Artery Disease

December 7, 2023 updated by: Keya Medical

A CCTA Image Assisted Triage Software for the Assessment of Patients With Suspected Coronary Artery Disease: a Retrospective, Multi-center, Blind-evaluation Study

The goal of this clinical trail is to evaluate the effectiveness and accuracy of the CCTA image assisted triage software(DeepVessel® Cardisight, Keya Medical.) for the triage of patients with suspected coronary artery disease.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

The CCTA images collected by each center within a certain period of time would be screened, desensitized, and then evaluated by the software and independent expert group respectively, to evaluate the effectiveness and accuracy of the coronary CT angiography image stenosis assisted triage software developed by Koyal Medical Technology Co.

Experiment group: Evaluated by the software Independent expert group: Evaluated by experts (≥5 years of CCTA experience required)

Study Type

Observational

Enrollment (Actual)

1093

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China
        • Fuwai Hospital, Chinese Academy of Medical Sciences
    • Guangdong
      • Guangzhou, Guangdong, China
        • The Pearl River Hospital of Southern Medical University
    • Guizhou
      • Zunyi, Guizhou, China
        • Affiliated Hospital of Zunyi Medical University
    • Hebei
      • Shijiazhuang, Hebei, China
        • The First Affiliated Hospital of Hebei Medical University
    • Hubei
      • Huanggang, Hubei, China
        • Huanggang Central Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Suspected patients with coronary heart disease.

Description

Inclusion Criteria:

  1. CCTA images acquired by CT detectors need to meet the following requirements:

    • Check Modal = CT
    • Number of detector rows ≥ 64 rows
    • Layer thickness ≤1mm
    • Layer spacing ≤1mm
    • Pixel pitch ≤ 0.5mm
    • Ball tube voltage ≥ 70kV
    • Number of layers ≥ 100 layers
  2. CCTA image quality score ≥ 3 (5-point Likert scale).

Exclusion Criteria:

  1. Severe coronary artery calcification, which in the judgment of readers affects the stenosis adjudicator;
  2. Previous percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG);
  3. Congenital anomalies of coronary artery origin or other malformations;
  4. Coronary artery occlusive lesions;
  5. Implantation of the pacemaker, internal defibrillator electrode, or prosthetic heart valve.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Suspected patients with coronary heart disease.
The coronary CT angiography (CCTA) images collected by each center within a certain period of time will be desensitized after the screening is successful. The final CCTA images were sent to an independent judgment expert group for diagnosis, the results of the test group and the independent judgment expert group were compared, and the clinical application of the coronary artery CT angiography image vascular stenosis auxiliary triage software developed by Keya Medical Technology Co., Ltd. was evaluated. Validity and Accuracy
Due to observational study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity and specificity of experiment group in triage for patients with suspected coronary artery disease
Time Frame: October 13,2022 to March 1,2023
Based on the results of the independent expert group, uses stenosis degree≥50% as the boundary for triage indication on a per-patient basis.
October 13,2022 to March 1,2023

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic time
Time Frame: October 13,2022 to March 1,2023
Independent expert group: recording the sum of image post-processing time (T1) and the time to produce the results (T2); Experimental group: recording the time from image post-processing to outputting results; Calculate the difference between the two groups.
October 13,2022 to March 1,2023
Patient as research unit
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the total conformity rate, KAPPA value, positive predictive value (PPV) and negative predictive value (NPV) of triage tips for patients with suspected coronary heart disease in the experimental group.
October 13,2022 to March 1,2023
Blood vessels were used as the research unit
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the total conformity rate, KAPPA value, positive predictive value (PPV) and negative predictive value (NPV) of triage tips for patients with suspected coronary heart disease in the experimental group.
October 13,2022 to March 1,2023
The vascular segment was used as the research unit
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the total conformity rate, KAPPA value, positive predictive value (PPV) and negative predictive value (NPV) of triage tips for patients with suspected coronary heart disease in the experimental group.
October 13,2022 to March 1,2023
Gender stratified statistics, respectively, with patients and blood vessels as research units
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease
October 13,2022 to March 1,2023
Manufacturer stratified statistics, respectively, with patients and blood vessels as research units
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease
October 13,2022 to March 1,2023
Row number stratified statistics, respectively, with patients and blood vessels as research units
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease
October 13,2022 to March 1,2023
The stratified statistics of tube voltage were conducted with patients and blood vessels as research units
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease
October 13,2022 to March 1,2023
Layer thickness stratified statistics, patients and blood vessels were used as research units
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease
October 13,2022 to March 1,2023
The patients and blood vessels were selected as the research units
Time Frame: October 13,2022 to March 1,2023
Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease
October 13,2022 to March 1,2023
Post-processing image quality evaluation
Time Frame: October 13,2022 to March 1,2023
Calculate the percentage of post-processing images with the image quality score of 2 or above in the total post-processing images, and the difference between the independent expert group and experimental group.
October 13,2022 to March 1,2023
Software performance evaluation
Time Frame: October 13,2022 to March 1,2023
From the function of use, ease of operation, stability to evaluate, divided into satisfactory, general, unsatisfactory three levels.
October 13,2022 to March 1,2023

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device Defects
Time Frame: October 13,2022 to March 1,2023
In the course of clinical trials, there are unreasonable risks that may endanger human health and life safety under normal use of medical devices, such as label errors, quality problems, and frequent failures
October 13,2022 to March 1,2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Bin Lu, Chinese Academy of Medical Sciences, Fuwai Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 9, 2023

Primary Completion (Actual)

June 8, 2023

Study Completion (Estimated)

February 29, 2024

Study Registration Dates

First Submitted

August 17, 2023

First Submitted That Met QC Criteria

December 7, 2023

First Posted (Estimated)

December 15, 2023

Study Record Updates

Last Update Posted (Estimated)

December 15, 2023

Last Update Submitted That Met QC Criteria

December 7, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Heart Disease

Clinical Trials on No intervention

3
Subscribe